ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Biogen VP to Keynote 2025 Bioelectronic Medicine Forum in NYC

News Source: Neurotech Reports

NEW YORK, N.Y., March 17, 2025 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that the Eighth Annual Bioelectronic Medicine Forum will take place on April 10, 2025. The one-day event will be held at the New York Academy of Medicine in Manhattan.

Medtech and pharmaceutical industry executive Lisa Shafer, Ph.D.
Image caption: Medtech and pharmaceutical industry executive Lisa Shafer, Ph.D., will keynote the 2025 Bioelectronic Medicine Forum in New York City on April 10.

Lisa Shafer, a vice president at biotech firm Biogen, will keynote the conference. Shafer has held executive management positions at key pharmaceutical firms such as Teva as well as neurotech firms such as Medtronic. In her distinguished career, she has helped bridge the gap between device and drug therapies as a chief scientific officer and product development executive. She earned her Ph.D. in neuroscience and neuroimmunology from Loyola University.

German firm Precisis, OSA startup LunOSA, European neuroprosthetics firm ReVision, and focused ultrasound firm Sanmai will present for the first time at the meeting. Also presenting will be executives from NeuroSigma, ANEUVO, and Synergia Medical. Venture capital professionals Jeff Chu from Features Capital, Mir Imran from InCube Ventures, and Jeffrey Scott Cohen from Ladenburg Thalmann & Co will participate in a session moderated by JoJo Platt devoted to investment in bioelectronic medicine.

Contributing editor Victor Pikov will moderate a session with executives from three firms in the neuromodulation space for treating obstructive sleep apnea, including market leader Inspire Medical Systems, and challengers Nyxoah and LivaNova.

There will also be several informative panel discussions on key topics such as investment, emerging technologies, and reimbursement. Neurotech Reports editors James Cavuoto, Jeremy Koff, and JoJo Platt will moderate sessions at the event.

Also at the event, former Axonics CEO Ray Cohen will sit down for a fireside chat with Neurotech Reports Senior Consulting Editor Jeremy Koff for a discussion on the bowel and bladder neuromodulation market.

Cirtec Medical is the Platinum Sponsor of the conference. MST is the Gold Sponsor. Osypka and Black Swan IP are Bronze Sponsors.

“Bioelectronic medicine merges some of the best attributes of biopharma and neurotech approaches to treating systemic disorders,” said James Cavuoto, editor and publisher at Neurotech Reports. “This eighth-annual conference will be a key meeting place for entrepreneurs and executives helping to build this industry.”

For more information on the 2025 Bioelectronic Medicine Forum, contact Neurotech Reports at 415 546 1259 or visit this link: http://neurotechreports.com/pages/bioelectronic-medicine-forum.html.

IMAGE link for media: https://www.Send2Press.com/300dpi/25-0317-s2p-LisaShafer-300dpi.jpg

Image caption: Medtech and pharmaceutical industry executive Lisa Shafer, Ph.D., will keynote the 2025 Bioelectronic Medicine Forum in New York City on April 10.


This press release was issued on behalf of the news source (Neurotech Reports), who is solely responsible for its accuracy, by Send2Press Newswire.

To view the original story, visit: https://www.send2press.com/wire/biogen-vp-to-keynote-2025-bioelectronic-medicine-forum-in-nyc/

Copr. © 2025 Send2Press® Newswire, Calif., USA. -- REF: S2P STORY ID: S2P124781 FCN24-3B

 

INFORMATION BELOW THIS PAGE, IF ANY, IS UNRELATED TO THIS PRESS RELEASE.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.